Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

Pseudomonas aeruginosa is intrinsically resistant to many antimicrobial drugs, making carbapenems crucial in clinical management. During July–October 2015 in the United States, we piloted laboratory-based surveillance for carbapenem-resistant P. aeruginosa (CRPA) at sentinel facilities in Georgia, N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Emerg Infect Dis
Main Authors: Walters, Maroya Spalding, Grass, Julian E., Bulens, Sandra N., Hancock, Emily B., Phipps, Erin C., Muleta, Daniel, Mounsey, Jackie, Kainer, Marion A., Concannon, Cathleen, Dumyati, Ghinwa, Bower, Chris, Jacob, Jesse, Cassidy, P. Maureen, Beldavs, Zintars, Culbreath, Karissa, Phillips, Walter E., Hardy, Dwight J., Vargas, Roberto L., Oethinger, Margret, Ansari, Uzma, Stanton, Richard, Albrecht, Valerie, Halpin, Alison Laufer, Karlsson, Maria, Rasheed, J. Kamile, Kallen, Alexander
Formato: Artigo
Idioma:Inglês
Publicado em: Centers for Disease Control and Prevention 2019
Assuntos:
Synopsis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590762/
https://ncbi.nlm.nih.gov/pubmed/31211681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2507.181200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados